CYCN·23255M204·US·equity·Healthcare - Biotechnology-Activist
CYCN (CYCLERION THERAPEUTICS INC) is held by 11 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($129,800), CITADEL ADVISORS LLC ($28,031), BlackRock, Inc. ($26,035). Net institutional sentiment: Mixed.
See how CYCN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer